BriaCell Therapeutics Corp.

TSX:BCT.TO

Biotechnology

Healthcare
$5.75 +18.88%

+$0.94 today

Market cap
$50.02M
Beta
1.53
P/E (TTM)
-0.3
EPS (TTM)
-$4.23
52W Low $3.68High $20.40

Volume 0.00M

Average 0.01M

BCT.TO Total Current Liabilities

All obligations due within one year.

BriaCell Therapeutics Corp.TSX: BCT.TO

Total Current Liabilities · Q3 FY2026 · quarter ended Apr 2026

Total current liabilities falls 17.1% from a year ago

Total current liabilities stood at $3.59M at the end of Q3 FY2026, down 17.1% from a year earlier and up 13.7% from the prior quarter. Over 3 fiscal years it compounded at +61.9% a year.

Context

  • Total current liabilities amounted to 13.3% of total assets at the end of Q3 FY2026, down 12.2 pp from a year earlier.
  • Total current liabilities increased in 2 of the last 3 fiscal years.

What to watch

Whether total current liabilities keeps falling in the next quarterly balance sheet after a -17.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterApr 2026
$3.59M+13.7% QoQ
Last fiscal yearJul 2025
$3.99M-46.5% YoY
Year agoApr 2025
$4.33M-17.1% since
Total Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-17.1%——
1 year-46.5%——
3-year CAGR+61.9%——
5-year CAGR——
10-year CAGR——

Total Current Liabilities history

USD · from the balance sheet

Latest · FY2025
3.99M USD
Year-over-year change
-46.5%
4-year CAGR
+63.6%

Total Current Liabilities vs competitors

How BCT.TO compares with its peers on the latest reported figures

No competitor Total Current Liabilities figures are available to compare.

Balance Sheet

USD
Metric
FY2021
Jul 2021
FY2022
Jul 2022
FY2023
Jul 2023
FY2024
Jul 2024
FY2025
Jul 2025
Cash & Equivalents57.27M41.04M21.25M862.09K10.53M
Short-term Investments00007.4M
Net Receivables12.57K24.1K717.74K1.37M566.73K
Inventory00000
Other Current Assets00000
Total Current Assets57.8M42.35M26.95M3.65M19.99M
Property, Plant & Equipment (Net)000388.18K297.84K
Goodwill00000
Intangible Assets245.61K230.34K215.07K199.8K185.16K
Long-term Investments000418.49K526.07K
Tax Assets00000
Other Non-current Assets0001.21M719.97K
Total Non-current Assets245.61K230.34K215.07K2.22M1.73M
Total Assets58.04M42.58M27.16M5.87M21.72M
Account Payables214.12K463.28K1.12M7.17M3.29M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities0000696.66K
Total Current Liabilities556.8K941.09K1.8M7.46M3.99M
Long-term Debt25.99K0000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities29.79M31.31M29.14M1.1M338.83K
Total Non-current Liabilities29.82M31.31M29.14M1.1M338.83K
Total Liabilities30.37M32.25M30.94M8.56M4.33M
Common Stock54.77M65.59M69.59M72.17M102.09M
Retained Earnings(29.14M)(60.35M)(80.65M)(85.44M)(112.14M)
Accumulated OCI(138.68K)(138.68K)(138.68K)(138.68K)27.99M
Other Stockholders Equity00011.03M0
Minority Interest000(302.52K)(548.67K)
Total Equity27.67M10.33M(3.78M)(2.68M)17.39M
Total Debt25.99K0000
Net Debt(57.24M)(41.04M)(21.25M)(862.09K)(10.53M)

BriaCell Therapeutics Corp.

TSX:BCT.TO

Intrinsic Alpha fair value

Locked

Current Price

$5.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.